Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Nicholas

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Open Forum Infectious Diseases|January 12, 2019
The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant <i>Enterobacteriaceae</i>Courtney L Luterbach, Ashley Boshe, Heather I Henderson, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2022
Imipenem/Relebactam Resistance in Clinical Isolates of Extensively Drug Resistant Pseudomonas aeruginosa: Inhibitor-Resistant β-Lactamases and Their Increasing ImportanceAndrea M Hujer, Christopher R Bethel, Magdalena A Taracila, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on MortalityLaura J Rojas, Madiha Salim, Eric Cober, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IVScott R Evans, Thuy Tien T Tran, Andrea M Hujer, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
Nosocomial Outbreak of Extensively Drug-Resistant Acinetobacter baumannii Isolates Containing <i>bla</i><sub>OXA-237</sub> Carried on a PlasmidAndrea M Hujer, Paul G Higgins, Susan D Rudin, et al.
Scientific Reports|July 29, 2025
A network analysis of carbapenem-resistant Klebsiella pneumoniae among healthcare facilitiesCourtney L Luterbach, Dana K Pasquale, Heather I Henderson, et al.
Journal of Clinical Microbiology|November 1, 2016
Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS IIIScott R Evans, Andrea M Hujer, Hongyu Jiang, et al.
Journal of Clinical Microbiology|May 25, 2017
Correction for Evans et al., "Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III"Scott R Evans, Andrea M Hujer, Hongyu Jiang, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2020
ARGONAUT II Study of the <i>In Vitro</i> Activity of Plazomicin against Carbapenemase-Producing Klebsiella pneumoniaeMichael R Jacobs, Caryn E Good, Andrea M Hujer, et al.
Journal of Medicinal Chemistry|May 19, 2020
A γ-Lactam Siderophore Antibiotic Effective against Multidrug-Resistant Gram-Negative BacilliJoel A Goldberg, Ha Nguyen, Vijay Kumar, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Open Forum Infectious Diseases|January 12, 2019
The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant <i>Enterobacteriaceae</i>Courtney L Luterbach, Ashley Boshe, Heather I Henderson, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2022
Imipenem/Relebactam Resistance in Clinical Isolates of Extensively Drug Resistant Pseudomonas aeruginosa: Inhibitor-Resistant β-Lactamases and Their Increasing ImportanceAndrea M Hujer, Christopher R Bethel, Magdalena A Taracila, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on MortalityLaura J Rojas, Madiha Salim, Eric Cober, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IVScott R Evans, Thuy Tien T Tran, Andrea M Hujer, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
Nosocomial Outbreak of Extensively Drug-Resistant Acinetobacter baumannii Isolates Containing <i>bla</i><sub>OXA-237</sub> Carried on a PlasmidAndrea M Hujer, Paul G Higgins, Susan D Rudin, et al.
Scientific Reports|July 29, 2025
A network analysis of carbapenem-resistant Klebsiella pneumoniae among healthcare facilitiesCourtney L Luterbach, Dana K Pasquale, Heather I Henderson, et al.
Journal of Clinical Microbiology|November 1, 2016
Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS IIIScott R Evans, Andrea M Hujer, Hongyu Jiang, et al.
Journal of Clinical Microbiology|May 25, 2017
Correction for Evans et al., "Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III"Scott R Evans, Andrea M Hujer, Hongyu Jiang, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2020
ARGONAUT II Study of the <i>In Vitro</i> Activity of Plazomicin against Carbapenemase-Producing Klebsiella pneumoniaeMichael R Jacobs, Caryn E Good, Andrea M Hujer, et al.
Journal of Medicinal Chemistry|May 19, 2020
A γ-Lactam Siderophore Antibiotic Effective against Multidrug-Resistant Gram-Negative BacilliJoel A Goldberg, Ha Nguyen, Vijay Kumar, et al.
Pageof 7